DZ Bank’s NxStage Medical Inc. NXTM Stock Holding History

DZ Bank’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-141,000	Closed	-$3.5M	–	1190
2018 Q1	$3.5M	Buy	+141,000	New	+$3.43M	0.01%	456

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

DZ Bank's NXTM Position: Q2 2018 in Review

DZ Bank sold out of NxStage Medical Inc. (NXTM) in Q2 2018, closing a stake of 141,000 shares — an estimated $3.5M sold.

DZ Bank first reported a position in NXTM in Q1 2018 and held it in 1 quarter. The position peaked at $3.5M in Q1 2018. 171 funds tracked by Wall St. Rank hold NXTM as of Q2 2018.

DZ Bank reported no remaining NxStage Medical Inc. position as of Q2 2018 after selling out during the quarter.
DZ Bank sold 141,000 NxStage Medical Inc. shares in Q2 2018, an estimated $3.5M.
DZ Bank first reported a position in NxStage Medical Inc. in Q1 2018 and held it in 1 quarter.
DZ Bank's NxStage Medical Inc. position peaked at $3.5M in Q1 2018.
171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.